CAS: 18417-89-5 - sangivamycin hydrate
Formel:C12H17N5O6
InChl:InChI=1S/C12H15N5O5/c13-9-6-4(10(14)21)1-17(11(6)16-3-15-9)12-8(20)7(19)5(2-18)22-12/h1,3,5,7-8,12,18-20H,2H2,(H2,14,21)(H2,13,15,16)/t5-,7-,8-,12-/m1/s1
InChI Key:InChIKey=OBZJZDHRXBKKTJ-JTFADIMSSA-N
SMILES:O=C(N)C1=CN(C=2N=CN=C(N)C21)C3OC(CO)C(O)C3O
- Synonyme:
- 4-Amino-7-β-<span class="text-smallcaps">D</span>-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide
- 4-amino-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide
- 4-amino-7-pentofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide
- 4-amino-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide hydrate
- 7-Deazaadenosine-7-carboxamide
- 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-7-β-<span class="text-smallcaps">D</span>-ribofuranosyl-
- NSC 65346
- Sangivamycin
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Sangivamycin REF: TM-T9605CAS: 18417-89-5 | 98.11% | 123,00 €~1.234,00 € | Do 05 Dez 24 | |
Sangivamycin hydrate REF: 7W-GA6883CAS: 18417-89-5 | - - - | Nachfragen | Do 05 Dez 24 | |
Sangivamycin REF: TR-S112503CAS: 18417-89-5 | - - - | 253,00 €~1.745,00 € | Mo 16 Dez 24 | |
Sangivamycin REF: 3D-AS181128CAS: 18417-89-5 | Min. 97 Area-% | 633,00 €~2.998,00 € | Di 17 Dez 24 |
Sangivamycin
- Inhibitoren
- Zellzyklus/Checkpoint
- PKC
- Nuklelosidantimetabolit/-analogon
- Mehr Kategorien anzeigen
- Zytoskeletale Signalgebung
Ref: TM-T9605
1mg | 123,00 € | ||
5mg | 269,00 € | ||
10mg | 407,00 € | ||
25mg | 661,00 € | ||
50mg | 922,00 € | ||
100mg | 1.234,00 € | ||
1mL*10mM (DMSO) | 352,00 € |
Ref: 7W-GA6883
Unbestimmte Größe | Nachfragen |
Sangivamycin
Kontrolliertes ProduktRef: TR-S112503
1mg | 253,00 € | ||
10mg | 981,00 € | ||
25mg | 1.745,00 € |
Sangivamycin
Ref: 3D-AS181128
1mg | 633,00 € | ||
2mg | 1.033,00 € | ||
5mg | 1.297,00 € | ||
10mg | 1.783,00 € | ||
25mg | 2.998,00 € |